Ledger.Open graph →
SEC Form D · filed December 9, 2020

Transposon Therapeutics, Inc

Offering
$45.2M
Sold
$45.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Menlo Park, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Brent R. Ahrens · Menlo Park, CADirectorJohn R. Pacifico · Menlo Park, CADirectorMark C. Jensen · Scottsdale, AZDirectorDennis Podlesak · Menlo Park, CAExec · DirectorEckard Weber, M.D · San Diego, CAExec · DirectorLynne R. Rollins · SAN DIEGO, CAExecMichael W. Mccormick · Scottsdale, AZDirectorDennis Podlesak · San Francisco, CAExec · DirectorEckard Weber, M.D · Westport, CTExec · DirectorJohn R. Pacifico · Menlo Park, CADirectorLynne R. Rollins · SAN DIEGO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗